United Therapeutics (UTHR) Tops Q3 EPS by 16c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $494.10 -0.7%
Revenue Growth %: -1.2%
Financial Fact:
Research and development: 45.9M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -1.2%
Financial Fact:
Research and development: 45.9M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.50, $0.16 better than the analyst estimate of $3.34. Revenue for the quarter came in at $408.2 million versus the consensus estimate of $402.35 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Aytu BioScience (AYTU) Tops Q4 EPS by 28c
- Top Wealth Group expects net profit to double in fiscal 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
